X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2023-08-30 | NRXP | Gorovitz Aaron | Dir | P - Purchase | $0.32 | +35,000 | 105,000 | +50% | +$11,197 | ||||||
2023-08-30 | NRXP | Hurvitz Chaim | Dir | P - Purchase | $0.29 | +70,000 | 2,214,793 | +3% | +$20,125 | ||||||
2023-08-23 | NRXP | Javitt Jonathan C | Chief Scientist, 10% | P - Purchase | $0.33 | +100,000 | 14,768,329 | +1% | +$33,000 | ||||||
2023-08-22 | NRXP | Javitt Jonathan C | Chief Scientist, 10% | P - Purchase | $0.32 | +200,000 | 14,668,329 | +1% | +$64,400 | ||||||
2022-12-16 | NRXP | Willard Stephen H | CEO | P - Purchase | $1.17 | +50,000 | 50,000 | New | +$58,500 | ||||||
2022-12-16 | NRXP | Van Voorhees Seth | CFO | P - Purchase | $1.10 | +30,000 | 46,337 | +184% | +$33,000 | ||||||
A | 2022-11-25 | NRXP | Van Voorhees Seth | CFO | P - Purchase | $1.11 | +16,337 | 16,337 | New | +$18,215 | |||||
2022-12-07 | NRXP | Javitt Jonathan C | Dir, 10% | S - Sale | $1.00 | -400,000 | 14,468,329 | -3% | -$400,000 | ||||||
M | 2022-11-29 | NRXP | Javitt Daniel C. | 10% | S - Sale | $1.50 | -22,171 | 9,634,793 | 0% | -$33,352 | |||||
2022-11-28 | NRXP | Flynn Patrick John | Dir | P - Purchase | $1.25 | +11,750 | 41,959 | +39% | +$14,663 | ||||||
2022-11-25 | NRXP | Van Voorhees Seth | CFO | P - Purchase | $1.11 | +16,337 | 16,377 | >999% | +$18,215 | ||||||
AM | 2022-11-16 | NRXP | Hurvitz Chaim | Dir | P - Purchase | $1.03 | +500,000 | 500,000 | New | +$514,905 | |||||
DM | 2022-11-16 | NRXP | Hurvitz Chaim | Dir | P - Purchase | $1.03 | +500,000 | 2,144,793 | +30% | +$514,905 | |||||
M | 2022-11-16 | NRXP | Javitt Daniel C. | 10% | S - Sale | $1.03 | -166,737 | 9,656,964 | -2% | -$171,138 | |||||
2022-11-11 | NRXP | Javitt Daniel C. | 10% | S - Sale | $1.01 | -49,200 | 9,823,701 | 0% | -$49,510 | ||||||
2022-07-29 | NRXP | Javitt Daniel C. | 10% | S - Sale | $1.01 | -784,063 | 9,872,901 | -7% | -$791,433 | ||||||
M | 2022-06-03 | NRXP | Javitt Daniel C. | 10% | S - Sale | $0.68 | -445,712 | 12,656,964 | -3% | -$303,910 | |||||
A | 2022-06-01 | NRXP | Javitt Jonathan C | Chief Scientist, 10% | P - Purchase | $0.58 | +100,000 | 14,868,329 | +1% | +$58,000 | |||||
2022-06-01 | NRXP | Javitt Jonathan C | Chief Scientist, 10% | P - Purchase | $58.00 | +100,000 | 14,868,329 | +1% | +$5,800,000 |
A | Amended filing |
D | Derivative transaction in filing (usually option exercise) |
E | Error detected in filing |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |